← Browse by Condition
Medical Condition
aml
Total Trials
8
Recruiting Now
8
Trial Phases
EARLY_Phase 1, Phase 1, Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for aml sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — aml Clinical Trials
How many clinical trials are currently recruiting for aml?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for aml, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for aml?
aml research spans Phase 1 (4 trials), Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a aml clinical trial?
Eligibility criteria for aml trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 4
Phase 2 2
Top Sponsors
2 trials
2 trials
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07126782 EARLY_Phase 1
Recruiting
The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT
Enrollment
10 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
NCT06611839 Phase 1, Phase 2
Recruiting
Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML
Enrollment
23 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
NCT07617285 Phase 1
Recruiting
Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML
Enrollment
27 pts
Location
China
Sponsor
Peking University People's Hos...
NCT06131801
Recruiting
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Enrollment
30 pts
Location
United States
Sponsor
Children's Hospital Medical Ce...
NCT07587944
Recruiting
Biomarkers in Bone Marrow Supernatant for Predicting AML Chemosensitivity
Enrollment
405 pts
Location
China
Sponsor
Fujian Medical University Unio...
NCT07163728
Recruiting
Leptin: A Marker for AML Chemo-Sensitivity
Enrollment
86 pts
Location
China
Sponsor
Fujian Medical University Unio...
NCT03050268
Recruiting
Familial Investigations of Childhood Cancer Predisposition
Enrollment
1,500 pts
Location
United States
Sponsor
St. Jude Children's Research H...
NCT04686682 Phase 1, Phase 2
Recruiting
A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
Enrollment
152 pts
Location
China
Sponsor
Jacobio Pharmaceuticals Co., L...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology